NYSE : RMD
ResMed Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 229.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 32.34B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 32.34B |
| Enterprise Value | 31.94B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Nov 12, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 140.66M |
| Shares Outstanding | 140.66M |
| Shares Change (YoY) | -1.35% |
| Shares Change (QoQ) | -1.08% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 80.57% |
| Float | 139.81M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 20.94 |
| Forward PE | 18.57 |
| PS Ratio | 5.64 |
| Forward PS | 5.50 |
| PB Ratio | 5.44 |
| P/TBV Ratio | 12.45 |
| P/FCF Ratio | 20.10 |
| P/OCF Ratio | 18.26 |
| PEG Ratio | 2.29 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 20.05 |
| EV / Sales | 5.57 |
| EV / EBITDA | 15.02 |
| EV / EBIT | 16.38 |
| EV / FCF | 19.85 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.65 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.38 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 26.40% |
| Return on Assets (ROA) | 14.76% |
| Return on Invested Capital (ROIC) | 26.88% |
| Return on Capital Employed (ROCE) | 28.32% |
| Weighted Average Cost of Capital (WACC) | 8.22% |
| Revenue Per Employee | $504,193 |
| Profits Per Employee | $140,120 |
| Employee Count | 11,370 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 2.16 |
Taxes
| Measure | Value |
|---|
| Income Tax | 418.61M |
| Effective Tax Rate | 20.81% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -9.34% |
| 50-Day Moving Average | 231.80 |
| 200-Day Moving Average | 224.89 |
| Relative Strength Index (RSI) | 41.76 |
| Average Volume (20 Days) | 1,239,897 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11.92M |
| Short Previous Month | 14.20M |
| Short % of Shares Out | 8.47% |
| Short % of Float | 8.53% |
| Short Ratio (days to cover) | 10.34 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.73B |
| Gross Profit | 3.54B |
| Operating Income | 1.95B |
| Pretax Income | 2.01B |
| Net Income | 1.59B |
| EBITDA | 2.13B |
| EBIT | 1.95B |
| Earnings Per Share (EPS) | $10.98 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.01B |
| Total Debt | 610.58M |
| Net Cash | 400.16M |
| Net Cash Per Share | $2.84 |
| Equity (Book Value) | 5.95B |
| Book Value Per Share | 42.29 |
| Working Capital | 2.18B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.77B |
| Capital Expenditures | -162.06M |
| Depreciation & Amortization | 176.27M |
| Net Borrowing | -260.00M |
| Free Cash Flow | 1.61B |
| FCF Per Share | $11.44 |
Margins
| Measure | Value |
|---|
| Gross Margin | 61.77% |
| Operating Margin | 34.02% |
| Pretax Margin | 35.09% |
| Profit Margin | 27.79% |
| EBITDA Margin | 37.09% |
| EBIT Margin | 34.02% |
| FCF Margin | 28.06% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.64 |
| Dividend Yield | 1.15% |
| Dividend Growth (YoY) | 11.50% |
| Years of Dividend Growth | 13 |
| Payout Ratio | 24.05% |
| FCF Payout Ratio | 23.08% |
| Buyback Yield | 1.35% |
| Shareholder Yield | 2.50% |
| Earnings Yield | 4.77% |
| FCF Yield | 4.97% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $265.11 |
| Price Target Difference | 15.30% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | 5.28% |
| EPS Growth Forecast (3Y) | 9.08% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 31, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 12.04 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |